ChemoMetec Gelecekteki Büyüme

Future kriter kontrolleri 5/6

ChemoMetec kazanç ve gelirin sırasıyla yıllık 26.8% ve 17.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 26.9% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 32.4% olacağı tahmin edilmektedir.

Anahtar bilgiler

26.8%

Kazanç büyüme oranı

26.87%

EPS büyüme oranı

Life Sciences kazanç büyümesi	19.9%
Gelir büyüme oranı	17.2%
Gelecekteki özkaynak getirisi	32.38%
Analist kapsamı	Low
Son güncelleme	05 Mar 2026

Gelecekteki son büyüme güncellemeleri

ChemoMetec A/S (CPH:CHEMM) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 07

Recent updates

ChemoMetec A/S' (CPH:CHEMM) 40% Cheaper Price Remains In Tune With Earnings

Feb 08

ChemoMetec A/S (CPH:CHEMM) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 07

ChemoMetec A/S (CPH:CHEMM) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Sep 15

ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing

Jul 07

At kr.554, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Jun 11

Getting In Cheap On ChemoMetec A/S (CPH:CHEMM) Is Unlikely

Apr 06

ChemoMetec A/S (CPH:CHEMM) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 08

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

Dec 12

ChemoMetec A/S (CPH:CHEMM) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Nov 09

We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

Sep 18

What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Jul 29

Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

Jul 29

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

Jul 03

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

Apr 15

What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

Mar 01

What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Mar 01

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 08

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Dec 21

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Nov 15

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 17

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Sep 15

Kazanç ve Gelir Büyüme Tahminleri

CPSE:CHEMM - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (DKK Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2028	805	359	281	384	4
6/30/2027	671	288	219	310	4
6/30/2026	556	228	161	250	4
12/31/2025	493	177	144	210	N/A
9/30/2025	494	182	144	209	N/A
6/30/2025	496	186	143	207	N/A
3/31/2025	478	178	136	192	N/A
12/31/2024	460	169	130	176	N/A
9/30/2024	434	153	108	153	N/A
6/30/2024	408	136	85	129	N/A
3/31/2024	405	140	104	138	N/A
12/31/2023	402	144	123	147	N/A
9/30/2023	423	161	118	150	N/A
6/30/2023	444	179	113	154	N/A
3/31/2023	453	179	117	156	N/A
12/31/2022	461	180	120	158	N/A
9/30/2022	445	170	120	167	N/A
6/30/2022	428	159	121	177	N/A
3/31/2022	393	145	94	148	N/A
12/31/2021	358	131	67	119	N/A
9/30/2021	320	110	75	114	N/A
6/30/2021	281	88	83	108	N/A
3/31/2021	262	81	79	105	N/A
12/31/2020	243	74	75	103	N/A
9/30/2020	229	67	60	87	N/A
6/30/2020	214	59	45	72	N/A
3/31/2020	206	54	39	66	N/A
12/31/2019	197	48	32	61	N/A
9/30/2019	186	45	N/A	60	N/A
6/30/2019	176	42	N/A	58	N/A
3/31/2019	158	37	N/A	50	N/A
12/31/2018	141	33	N/A	42	N/A
9/30/2018	127	25	N/A	34	N/A
6/30/2018	113	18	N/A	25	N/A
3/31/2018	107	15	N/A	20	N/A
12/31/2017	102	13	N/A	14	N/A
9/30/2017	96	10	N/A	12	N/A
6/30/2017	90	7	N/A	10	N/A
3/31/2017	88	6	N/A	13	N/A
12/31/2016	85	5	N/A	16	N/A
9/30/2016	85	8	N/A	17	N/A
6/30/2016	85	10	N/A	17	N/A
3/31/2016	80	11	N/A	16	N/A
12/31/2015	75	12	N/A	14	N/A
9/30/2015	68	10	N/A	14	N/A
6/30/2015	61	8	N/A	13	N/A
3/31/2015	56	5	N/A	9	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CHEMM 'nin tahmini kazanç büyümesi (yıllık 26.8% ) tasarruf oranının ( 1.9% ) üzerindedir.

Kazançlar ve Piyasa: CHEMM şirketinin kazançlarının (yıllık 26.8% ) Danish pazarından (yıllık 7.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CHEMM şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: CHEMM şirketinin gelirinin (yıllık 17.2% ) Danish pazarından (yıllık 4.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CHEMM şirketinin gelirinin (yıllık 17.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CHEMM 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 32.4 %)

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2026/03/13 23:13
Gün Sonu Hisse Fiyatı	2026/03/13 00:00
Kazançlar	2025/12/31
Yıllık Kazançlar	2025/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, raporlarımızı nasıl kullanacağınız konusunda kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

ChemoMetec A/S 8 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Mads Brinkmann Andersen	Berenberg
Kallum Titchmarsh	BofA Global Research
Simon Larsson	Danske Bank

ChemoMetec Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

ChemoMetec A/S (CPH:CHEMM) Just Reported Earnings, And Analysts Cut Their Target Price

Price target decreased by 7.0% to kr.809

Chemometec A/S Maintains Earnings Guidance for the Year 2025

Price target increased by 9.7% to kr.870

ChemoMetec A/S Updates Earnings Guidance for the Year 2025-26

Price target increased by 17% to kr.793

Recent updates

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 32%

ChemoMetec A/S' (CPH:CHEMM) 40% Cheaper Price Remains In Tune With Earnings

ChemoMetec A/S (CPH:CHEMM) Just Reported Earnings, And Analysts Cut Their Target Price

Price target decreased by 7.0% to kr.809

First half 2026 earnings released: EPS: kr.5.40 (vs kr.5.94 in 1H 2025)

Chemometec A/S Maintains Earnings Guidance for the Year 2025

Price target increased by 9.7% to kr.870

Chief Executive Officer recently bought kr.1.0m worth of stock

Earnings Tell The Story For ChemoMetec A/S (CPH:CHEMM) As Its Stock Soars 27%

ChemoMetec A/S Updates Earnings Guidance for the Year 2025-26

Price target increased by 17% to kr.793

Now 24% overvalued after recent price rise

ChemoMetec A/S Approves to Distribute Dividend

Dividend increased to kr.7.00

Now 20% overvalued after recent price rise

Calculating The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Investor sentiment improves as stock rises 20%

ChemoMetec A/S, Annual General Meeting, Oct 09, 2025

ChemoMetec A/S (CPH:CHEMM) Looks Just Right With A 26% Price Jump

Price target increased by 8.6% to kr.677

ChemoMetec A/S (CPH:CHEMM) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Chemometec A/S Provides Earnings Guidance for the Financial Year 2025/26

Full year 2025 earnings: EPS misses analyst expectations

Now 21% overvalued after recent price rise

ChemoMetec A/S' (CPH:CHEMM) Popularity With Investors Is Under Threat From Overpricing

New minor risk - Share price stability

At kr.554, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Getting In Cheap On ChemoMetec A/S (CPH:CHEMM) Is Unlikely

Investor sentiment deteriorates as stock falls 17%

ChemoMetec A/S (CPH:CHEMM) Analysts Are Pretty Bullish On The Stock After Recent Results

First half 2025 earnings released: EPS: kr.5.94 (vs kr.4.05 in 1H 2024)

Price target increased by 12% to kr.613

Investor sentiment improves as stock rises 16%

Chemometec A/S Updates Earnings Guidance for the 2024/2025 Financial Year

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

ChemoMetec A/S Updates Earnings Guidance for the Financial Year 2024-2025

Deputy Chairman & Senior Advisor recently bought kr.3.2m worth of stock

Price target increased by 15% to kr.505

Consensus EPS estimates increase by 11%

ChemoMetec A/S (CPH:CHEMM) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

New major risk - Share price stability

ChemoMetec A/S Maintains Earnings Guidance for the Full-Year 2024-2025

Investor sentiment improves as stock rises 19%

Insufficient new directors

ChemoMetec A/S (CPSE:CHEMM) completed the acquisition of Ovizio Imaging Systems NV/SA.

ChemoMetec A/S Revises Earnings Guidance for the Financial Year 2024/2025

Investor sentiment improves as stock rises 21%

ChemoMetec A/S Approves Dividend

Upcoming dividend of kr.4.00 per share

ChemoMetec A/S (CPSE:CHEMM) submitted an indicative offer to acquire Ovizio Imaging Systems NV/SA.

We Think That There Are More Issues For ChemoMetec (CPH:CHEMM) Than Just Sluggish Earnings

Dividend of kr.4.00 announced

Price target increased by 8.0% to kr.473

Full year 2024 earnings: EPS exceeds analyst expectations

ChemoMetec A/S provides earnings guidance for the year 2024/25

Investor sentiment improves as stock rises 17%

ChemoMetec A/S to Report Fiscal Year 2025 Results on Sep 11, 2025

What ChemoMetec A/S' (CPH:CHEMM) 27% Share Price Gain Is Not Telling You

Earnings Not Telling The Story For ChemoMetec A/S (CPH:CHEMM) After Shares Rise 27%

Investor sentiment improves as stock rises 15%

What Is ChemoMetec A/S's (CPH:CHEMM) Share Price Doing?

ChemoMetec A/S Announces CFO Changes

Independent Director recently bought kr.450k worth of stock

Investor sentiment improves as stock rises 17%

Now 20% overvalued

Price target increased by 14% to kr.513

Now 21% overvalued

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%